An expanded PRS (EPRS) approach combining polygenic risk scores and rare variant clustering enhances cancer risk stratification for breast and prostate cancers. High-PRS groups with rare high-impact gene variants have up to 15- and 22-fold higher risk for breast and prostate cancers, respectively, compared to intermediate-PRS groups without rare variants.
- Joon Ho Kang
- Youngkee Lee
- Byung-Chul Lee
